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Linking dental pathologies and cancer via Wnt signalling
Pierfrancesco Pagella, Claudio Cantù and Thimios A. Mitsiadis
In search of ideal therapeutic targets
Great efforts have been made over the past decades 
to discover new therapeutic targets for a big variety of 
human pathologies. Most of the studies dealing with 
severe pathological conditions such as cancers and tissue 
malformations are focused on the role of either widely 
recognized master controlling genes such as ras and myc 
or pivotal components of key signalling pathways, among 
which Wnt and Notch [1, 2]. However, these genes and 
molecules are fundamental for proper embryogenesis as 
well as for tissue and organ homeostasis and regeneration, 
where they regulate cell proliferation, migration, 
differentiation and apoptosis. The precise timing and 
localization of their activation are important to ensure the 
appropriate cellular functions in physiological conditions. 
Thus, their indiscriminate targeting is not desirable, due to 
both the high risk of severe side effects and the certainty 
of broad phenotypic consequences. On the contrary, 
optimal therapeutic targets should be selected based on 
their tissue, time and pathology specific roles. Here, we 
suggest a paradigmatic example of such target molecules 
that could be represented by the Wnt/β-catenin signalling 
components Bcl9 and Bcl9l.
New candidates in dental pathologies 
Our recent studies performed in rodent teeth showed 
that the transcriptional modulators of the Wnt signalling 
pathway, Bcl9 and Bcl9l (Bcl9/9l), possess a role in the 
fine-tuning of the tooth enamel [3]. The peculiar structural 
and chemical organization of the enamel, which is the 
most mineralized and hardest tissue of the human body, 
is of crucial importance for its ability to resist insults 
such as mechanical wear, stress, bacterial toxins and 
acids that can lead to various dental pathologies. Despite 
their clinical relevance, the molecular mechanisms 
responsible for dental defects and the observed variability 
in tooth properties in humans are essentially unknown [4]. 
Mutations in Bcl9/9l in the mouse affect the fine structure 
of enamel, thus making it more fragile and likely prone 
to bacterial infiltrations that facilitate caries progression 
[3]. In ameloblasts, which are the cells responsible for 
enamel matrix formation, Bcl9/9l possess a cytoplasmic 
function, quite in contrast to their previously recognized 
role as transcriptional activators (Figure 1). In dental 
tissues, together with their known binding partner Pygo, 
they interact with secretory vesicles to modulate the 
secretion and maturation of the enamel matrix. This 
newly discovered function of Bcl9/9l strongly suggests 
that genetic variations might influence the predisposition 
to dental defects related to enamel quality in humans. The 
cytoplasmic pathway driven by Bcl9/9l appears to be a 
specialized tissue-specific mechanism that regulates the 
fine-tuning of enamel but not the overall formation of 
teeth. We suggest that this mechanism might represent 
an ideal target for diagnostic and possibly therapeutic 
interventions aiming at preserving the structural stability 
of enamel [3].
From teeth to cancer
Bcl9/9l are also widely expressed in other tissues, 
such as the intestinal epithelium. Here, they fine-tune the 
expression of Wnt targets, including genes involved in 
stem cell function [5]. Similarly to the effects observed 
in teeth, conditional deletion of Bcl9/9l in the intestinal 
epithelium does not exert dramatic effects on its 
development and homeostasis [5, 6]. However, in injured 
intestinal epithelium, the absence of Bcl9/9l impairs its 
regeneration that causes higher mouse mortality [6]. 
This effect is of extreme importance as it is now well 
established that the same mechanisms responsible for 
tissue regeneration are abnormally activated in several 
cancers [7]. Cancers could be seen as wounds that never 
heal and therefore the molecular mechanisms involved 
in tissue regeneration may play a leading role in tumour 
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Figure 1: Schematic model summarizing the roles of 
Bcl9/9l in development and disease according to their 
nuclear or cytoplasmic localization.
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progression and metastasis [7]. Consistently, the loss of 
Bcl9/9l in colorectal cancers has striking effects on their 
progression and metastatization [6, 8]. 
Taken together these findings indicate that Bcl9/9l 
modulate and fine-tune tissue-specific processes. Their 
activation and inhibition lead to consequences that do not 
affect homeostatic conditions but impair/debilitate cell-
specific responses required in tissue fine-tuning during 
regeneration and pathology. Bcl9/9l represent promising 
targets as their action fall precisely within the so-called 
“therapeutic window”. Challenging protein networks 
important in a regenerative context could constitute an 
innovative experimental approach aimed at identifying 
relevant targets hijacked during tissue-specific diseases 
and cancers. The ideal molecular targets should reside 
within the set of molecules whose perturbations do not 
affect homeostasis, but modulate tissue regeneration and 
cancer. Their particular mechanism and specificity make 
Bcl9/9l a paradigmatic example of this view. Our findings 
might indicate that many other proteins, commonly 
considered as mere tissue-specific effectors, could exert 
specific and variable functions that would make them 
optimal therapeutic targets for tissue-specific pathologies.
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